JPMorgan Chase & Co. Issues Pessimistic Forecast for Bath & Body Works (NYSE:BBWI) Stock Price

Bath & Body Works (NYSE:BBWIGet Free Report) had its price target decreased by equities research analysts at JPMorgan Chase & Co. from $26.00 to $15.00 in a research report issued to clients and investors on Thursday,MarketScreener reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price points to a potential upside of 1.08% from the stock’s previous close.

Other analysts have also recently issued reports about the stock. Wall Street Zen cut shares of Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Wells Fargo & Company decreased their price target on Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday. Jefferies Financial Group dropped their price target on Bath & Body Works from $32.00 to $28.50 and set a “hold” rating for the company in a report on Monday, October 13th. Bank of America cut their price objective on Bath & Body Works from $40.00 to $32.00 and set a “buy” rating for the company in a research report on Thursday. Finally, The Goldman Sachs Group lowered shares of Bath & Body Works from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $39.00 to $17.00 in a report on Thursday. Seven equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $26.90.

View Our Latest Report on BBWI

Bath & Body Works Stock Performance

NYSE:BBWI opened at $14.84 on Thursday. The firm’s 50-day moving average is $24.58 and its 200-day moving average is $28.14. The company has a market cap of $3.06 billion, a price-to-earnings ratio of 4.40, a PEG ratio of 0.86 and a beta of 1.53. Bath & Body Works has a 52-week low of $14.27 and a 52-week high of $41.87.

Bath & Body Works (NYSE:BBWIGet Free Report) last released its quarterly earnings data on Thursday, November 20th. The company reported $0.35 EPS for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). The business had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.64 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.Bath & Body Works’s revenue was down 1.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.49 earnings per share. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. Equities analysts predict that Bath & Body Works will post 3.3 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. First Horizon Corp bought a new stake in shares of Bath & Body Works during the third quarter worth approximately $29,000. Stonehage Fleming Financial Services Holdings Ltd acquired a new stake in Bath & Body Works during the 2nd quarter worth $33,000. SVB Wealth LLC bought a new stake in shares of Bath & Body Works during the 1st quarter valued at $35,000. Geneos Wealth Management Inc. raised its position in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares during the last quarter. Finally, Parallel Advisors LLC grew its stake in shares of Bath & Body Works by 63.3% during the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after purchasing an additional 481 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

See Also

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.